Related Experiment Video
Updated: Jan 20, 2026
Canonical Wnt Signaling Pathway and Associated Diseases
Long non-coding RNA ENST00000434223 inhibits the progression of renal cancer through Wnt/hygro-catenin signaling
1Department of Urology, Gansu Provincial Hospital, Lanzhou, China. huangxiande720@sina.com.
Objective:
The purpose of this study was to determine the function of long non-coding RNA (LncRNA) ENST00000434223 (Lnc ENST) in renal carcinoma, and to explore the potential molecular mechanism.
Patients And Methods:
Quantitative Real-Time-Polymerase Chain Reaction (qRT-PCR) was used to detect the expressions of lncRNA ENST00000434223 and Wnt/β-catenin pathway-related mRNAs in tissues and cells of renal cancer. Chi-square test was performed to figure out the relationship between lncRNA ENST00000434223 and clinic-pathologic features of renal cancer patients. Besides, si-NC, si-ENST00000434223, pcDNA-NC and pcDNA-ENST00000434223 were transfected into renal cancer cells. The proliferative ability, metastasis and invasiveness of cells were detected using Cell Counting Kit-8 (CCK-8) and transwell assay, respectively. Lastly, the activation of the Wnt/hygro-catenin signal transduction pathway was evaluated by TOP/FOP Wnt Luciferase reporter assay and Western blot.
Results:
The expressions of Wnt2b and β-catenin were significantly increased in renal carcinoma, while E-cadherin was markedly down-regulated. Lowly expressed ENST00000434223 was involved in the poor prognosis of patients with renal cancer. In addition, down-regulating ENST00000434223 could enhance the viability, metastasis and invasiveness of renal cancer cells. However, overexpressing ENST00000434223 remarkably weakened the above cell functions. At the same time, interference or overexpression of ENST00000434223 could affect the expression level of proteins related to the Wnt/β-catenin signal pathway.
Conclusions:
LncRNA ENST00000434223 inhibits the progression of renal cancer through the Wnt/shell-catenin signal pathway.
Insights
Long non-coding RNA ENST00000434223 (LncRNA ENST) inhibits renal cancer progression. This study found LncRNA ENST suppresses tumor viability, metastasis, and invasiveness via the Wnt/β-catenin pathway.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Renal carcinoma is a significant health concern.
- Long non-coding RNAs (LncRNAs) play crucial roles in various cancers.
- The specific function of LncRNA ENST00000434223 in renal cancer remains largely unexplored.
Purpose of the Study:
- To elucidate the functional role of LncRNA ENST00000434223 in renal carcinoma.
- To investigate the underlying molecular mechanisms involving the Wnt/β-catenin pathway.
Main Methods:
- Quantitative Real-Time-Polymerase Chain Reaction (qRT-PCR) for expression analysis.
- Cell proliferation, metastasis, and invasion assays (CCK-8, Transwell).
- Wnt/β-catenin pathway activation assessment (Luciferase reporter assay, Western blot).
Main Results:
- LncRNA ENST00000434223 expression is reduced in renal carcinoma, correlating with poor prognosis.
- Downregulation of LncRNA ENST00000434223 promotes cancer cell viability, metastasis, and invasion.
- Modulating LncRNA ENST00000434223 affects Wnt/β-catenin pathway signaling proteins.
Conclusions:
- LncRNA ENST00000434223 acts as a tumor suppressor in renal cancer.
- Inhibition of renal cancer progression by LncRNA ENST00000434223 is mediated through the Wnt/β-catenin signaling pathway.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
13:00Studying Wnt Signaling During Patterning of Conducting Airways
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
06:29Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression
11:14Modeling Paracrine Noncanonical Wnt Signaling In Vitro
